About Gentiva Health Services (NASDAQ:GTIV)
Gentiva Health Services, Inc. is engaged in providing home health services and hospice services. The Company provides home health and hospice services to more than 350,000 patients from more than 420 community locations. Its full range of clinical services includes: skilled nursing, physical, occupational and speech-language therapy, cardiac and pulmonary care, neurorehabilitation, wound care, disease and pain management, medication management and education, patient education to promote self-management, treatment for balance problems that can lead to fall risks and hospice services. The Company's Hospice segment serves terminally ill patients and their families through more than 150 locations operating in 29 states. Hospice operations are also organized in a single division, which is staffed with clinical, operational, human resource, finance and sales teams.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Home Healthcare Services
- Sub-Industry: Health Care Services
- Symbol: NASDAQ:GTIV
- CUSIP: 37247A10
- Web: www.gentiva.com
- 50 Day Moving Avg: $19.00
- 200 Day Moving Avg: $19.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.99
- P/E Growth: 0
- Net Margins: 1.71%
- Return on Assets: 2.76%
Frequently Asked Questions for Gentiva Health Services (NASDAQ:GTIV)
What is Gentiva Health Services' stock symbol?
Gentiva Health Services trades on the NASDAQ under the ticker symbol "GTIV."
How were Gentiva Health Services' earnings last quarter?
Gentiva Health Services, Inc. (NASDAQ:GTIV) announced its quarterly earnings results on Friday, November, 14th. The company reported $0.28 earnings per share for the quarter, hitting analysts' consensus estimates of $0.28. The company had revenue of $498.01 million for the quarter, compared to analyst estimates of $498 million. View Gentiva Health Services' Earnings History.
Who are some of Gentiva Health Services' key competitors?
Some companies that are related to Gentiva Health Services include Partnership Assurance Group PLC (PA), Johnson & Johnson (JNJ), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Koninklijke Philips NV (PHG), Shire PLC (SHP), Edwards Lifesciences Corp (EW), Hospira (HSP), IDEXX Laboratories (IDXX), Henry Schein (HSIC), Smith & Nephew plc (SN), Teleflex Incorporated (TFX), Omnicare (OCR), Alkermes Plc (ALKS), VCA (WOOF), NMC Health PLC (NMC), Catalent (CTLT) and Valeant Pharmaceuticals Intl (VRX).
How do I buy Gentiva Health Services stock?
Shares of Gentiva Health Services can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Gentiva Health Services' stock price today?
MarketBeat Community Rating for Gentiva Health Services (NASDAQ GTIV)MarketBeat's community ratings are surveys of what our community members think about Gentiva Health Services and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Gentiva Health Services stock can currently be purchased for approximately $19.19.
Consensus Ratings for Gentiva Health Services (NASDAQ:GTIV) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Gentiva Health Services (NASDAQ:GTIV)
Analysts' Ratings History for Gentiva Health Services (NASDAQ:GTIV)
(Data available from 10/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|11/26/2015||Robert W. Baird||Upgrade||Underperform -> Neutral||N/A|
Earnings History for Gentiva Health Services (NASDAQ:GTIV)Earnings History by Quarter for Gentiva Health Services (NASDAQ GTIV)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/14/2014||Q3 2014||$0.28||$0.28||$498.00 million||$498.01 million||View||N/A|
|8/5/2014||Q214||$0.24||$0.38||$492.31 million||$498.00 million||View||N/A|
|5/7/2014||Q114||$0.11||$0.13||$491.51 million||$487.50 million||View||N/A|
|3/4/2014||Q413||$0.30||($0.14)||$496.51 million||$486.10 million||View||N/A|
|8/1/2013||Q2 2013||$0.21||$0.22||$416.83 million||$414.40 million||View||N/A|
|5/9/2013||Q1 2013||$0.30||$0.23||$427.95 million||$415.60 million||View||N/A|
|2/7/2013||Q4 2012||$0.34||$0.31||$432.77 million||$425.00 million||View||N/A|
|11/1/2012||Q312||$0.28||$0.32||$428.44 million||$424.40 million||View||N/A|
Earnings Estimates for Gentiva Health Services (NASDAQ:GTIV)
Current Year EPS Consensus Estimate: $1.05 EPS
Next Year EPS Consensus Estimate: $1.20 EPS
Dividend History for Gentiva Health Services (NASDAQ:GTIV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Gentiva Health Services (NASDAQ:GTIV)Insider Trades by Quarter for Gentiva Health Services (NASDAQ:GTIV)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/25/2013||David Causby||EVP||Sell||9,223||$12.25||$112,981.75|| |
|6/17/2013||Rodney D Windley||Chairman||Sell||10,000||$11.73||$117,300.00|| |
|5/15/2013||Rodney D Windley||Chairman||Sell||10,000||$10.39||$103,900.00|| |
|2/15/2013||John N Camperlengo||SVP||Sell||6,000||$11.50||$69,000.00|| |
|2/15/2013||Rodney D Windley||Chairman||Sell||10,000||$11.31||$113,100.00|| |
Headline Trends for Gentiva Health Services (NASDAQ:GTIV)
Latest Headlines for Gentiva Health Services (NASDAQ:GTIV)
Gentiva Health Services (GTIV) Chart for Saturday, October, 21, 2017